Forest and Deloitte to collaborate

Share this article:

ConvergeHEALTH by Deloitte has entered into a multi-year collaboration with Forest Labs and Intermountain Healthcare to conduct outcomes research. The collaboration will leverage next-generation analytics, insights from real-world evidence and collaborative research to better understand patient outcomes and success factors. Its initial focus is respiratory disease.

Launched in February, ConvergeHEALTH is Deloitte's business unit combining analytics products with the organization's consulting capabilities.

Dr. Shailja Dixit, executive director, HEOR, at Forest, said, “this collaboration has the potential to provide unique insights into respiratory disease.” The parties said they will leverage EMR data to help understand associated outcomes for treatments and filter for sub-populations using phenotypic characteristics and medical associations.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"